Loading...
Uploaded by NewAmericaFoundation on Jul 14, 2009
ane Horvath of Merck & Co., Inc. describes her company's views on comparative effectiveness research and details one current project looking at oral diabetes medication. For more information, please visit: http://www.newamerica.net/hc4hr
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)